Best Life Sciences Companies in Mountain View, United States

Developer of a non-invasive medical device to open the blood-brain barrier. It offers a low-power ultrasound technology-based device to improve drug delivery for patients with brain cancers, Alzheimer's, Parkinson's, and Epilepsy.

Funding rounds

• Nov 2025Seed$8M
• Sep 2024Grant (prize money)$399.4K
• May 2020Grant (prize money)$225K

Founders & team

Bhaskar RamamurthyFounder/CTORyan DittamoreCEO

Investors

National Science Foundation, Sonder Capital, Shanda, Angel Physicians Fund, SmartGateVC, R42 Group

Bioelectronic device technology for the treatment of autoimmune diseases. It offers a neuromodulation device for treating inflammatory bowel disease through parasympathetic nervous system stimulation.

Rejuvenation Technologies is developing nucleoside-modified TERT mRNA. The nucleoside-modified TERT mRNA is used to extend the telomeres. It is based on the technology that telomere shortening affects cell function. The company has developed in-vivo based therapeutics (in-vivo testing phase) and cell therapies (out-licensing phase) for aging and treating fatal diseases.

Funding rounds

• Apr 2025Grant (prize money)—
• Sep 2024Grant (prize money)$325K
• Aug 2024Grant (prize money)$1.1M
• Oct 2023Seed—

Founders & team

Glenn MarkovCo-FounderJohn RamunasCo-Founder & CEO

Investors

Khosla Ventures, Shanda, Asymmetry Ventures, Merchant Adventure Investment Advisors, Longevitytech.fund, Y Combinator

Tech stack

WordpressMysqlPhpAstraWpformsJetpack

Provider of microbiotics for women's health and GI diseases. Its proprietary approach leverages the differences between healthy and diseased microbiomes to develop new microbial drugs. Its lead candidate is a Lactobacillus strain that is in phase II trials for recurrent bacterial vaginosis and recurrent urinary tract infections. In addition, the company has a strain of Clostridium butyricum in phase II trials to treat antibiotic-associated diarrhea and in preclinical testing for inflammatory bowel disease, and it is also investigating a possible application for HIV infections.

Funding rounds

• May 2025Grant (prize money)$295.9K
• Aug 2020Grant (prize money)$1.5M
• Apr 2016Grant (prize money)$225K
• Apr 2012Grant (prize money)$2.9M

Founders & team

Peter LeeFounder and Chairman

Investors

HHS

Tech stack

DiviFlywheelGodaddyGoogle AnalyticsGoogle Font ApiGoogle Workspace

Developer of minimally invasive surgical instruments. The company focuses on the development of an investigational medical device for use during minimally invasive laparoscopic hysterectomy.

Funding rounds

• Apr 2025Grant (prize money)$1M
• Jan 2023Series A$8M
• Sep 2022Grant (prize money)$1.7M
• Dec 2020Grant (prize money)$256K

Founders & team

Alexey SalaminiCo-Founder & CEOSteve KimCo-Founder

Investors

Organon, HHS, National Science Foundation

Wearable double electric breast pump kits. The company provides breast-pumps, bras, pumping accessories, bags, and body care products. Its pumping systems are connected by mobile application.

Funding rounds

• Jan 2024Series D$81.4M
• Apr 2021Series C$26.8M
• Sep 2020Series C$55M
• Dec 2019Series B$20M

Founders & team

John ChangCo-Founder & Chief Technical OfficerJosh MakowerFounder & ChairmanSarah OLearyCEO

Investors

New Enterprise Associates, Meritech, Lightstone Ventures, Perceptive Advisors, Endeavour Vision, Pura Vida Investments

Tech stack

Apple Icloud MailApple PayAuraBootstrapCart FunctionalityCloudflare

R3 Vascular is a manufacturer of medical device metallic stents for the treatment of peripheral arterial diseases. The company offers bioresorbable vascular scaffolds (BVS) technology with a sirolimus coating which is having anti-inflammatory properties and can be used for the treatment of peripheral arterial disease below the knee (BTK).

Materna Medical provides a device for women’s pelvic health. It develops devices Milli, a vaginal and pelvic floor dilator, and Materna Prep, to reduce maternal childbirth-related injuries, like perineal lacerations, during vaginal delivery.

Funding rounds

• May 2024Series B$20M
• Jul 2022Series B$22M
• Apr 2021Series A$10M
• Oct 2019Grant (prize money)$50K

Founders & team

Michael StewartCo-FounderMark JuravicCo-FounderTracy MacnealPresident and CEO

Investors

Wavemaker 360, Womens VC Fund II, Golden Seeds, Black Capital, Shatter Fund, Band of Angels

Tech stack

Cart FunctionalitySquarespace CommerceSquarespaceStimulusGoogle AnalyticsPriority Hints

Kinetic River is the provider of flow cytometer and laser beam stabilizer. The company provides fluorescence lifetime flow cytometer and molecular flow cytometer for cell measurement, and laser beam stabilizer for targeting the cells. It also provides consulting services to diagnostic device companies.

Funding rounds

• Aug 2024Grant (prize money)$356.5K
• Apr 2022Grant (prize money)$2.5M
• Apr 2019Grant (prize money)$225K
• Apr 2018Grant (prize money)$224.8K

Founders & team

Giacomo VaccaFounder

Investors

HHS

Tech stack

WordpressMysqlPhpHashthemes TotalYoast SeoNginx

DNAnexus provides cloud-based genome informatics and data management tools for enterprises and organizations that are engaged in the development and delivery of genomic medicine. The company’s platform enables the companies to analyze raw sequencing data; integrate genomic data with clinical and other phenotypic data, and collaborate seamlessly.

Funding rounds

• Mar 2022Series H$200M
• Jun 2020Series G$100M
• Feb 2019Conventional Debt—
• Feb 2019Series F$68M

Founders & team

Richard DalyCEO

Investors

Foresite Capital, Genuity Science, Google Ventures, MidCap Financial, Claremont Creek Ventures, M12

Tech stack

Amazon SesAmazon Web ServicesApple Icloud MailBootstrapCdnjsClipboard.Js

Developer of engineered IgM antibodies for the treatment of cancer patients. The company has created a proprietary IgM technology platform for the development of IgM antibodies agonists against oncology, immunology, and inflammation targets.

Funding rounds

• Jul 2023Post IPO$120M
• Jul 2019Series C$102M
• Dec 2017Series A$2.1M
• Sep 2011Seed$671.4K

Founders & team

Fred SchwarzerCEO

Investors

Redmile Group, Janus Henderson Investors, Vivo Capital, Haldor Topsoe

EEG system for the diagnosis of seizures. It has developed point-of-care diagnostic devices. The offering includes Ceribell EEG Headband and Ceribell EEG Recorder. The headbands have features for data recording, EEG signal display, brain activity analysis, and EEG monitoring with alerts.

Funding rounds

• Sep 2022Series C$50M
• Apr 2021Series C$102.5M
• May 2020Venture Debt$20M
• Sep 2018Series B$35M

Founders & team

Chris ChafeCo-Founder

Investors

Longitude Capital, The Rise Fund, RA Capital Management, Redmile Group, Red Tree Venture Capital, Horizon

Tech stack

ActivecampaignAmazon CloudfrontAmazon Web ServicesApache Http ServerApple Icloud MailBootstrap